Dr. Reid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3855 HEALTH SCIENCES DR Rm 2238
Moores UCSD Cancer Center
La Jolla, CA 92093Phone+1 858-822-6276Fax+1 858-822-6288- Is this information wrong?
Summary
- Dr. Erin Reid is a hematologist in La Jolla, CA and is affiliated with UC San Diego Health. She received her medical degree from University of California San Francisco School of Medicine and has been in practice 18 years. She is experienced in Hodgkin and non-Hodgkin lymphomas with a focus in HIV/AIDS-related lymphoma and Kaposi sarcoma.
Education & Training
Stanford UniversityM.S., Epidemiology/Clinical Research, 2003 - 2006
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2004
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2001 - 2004- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2000 - 2001
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1999 - 2000
University of California San Francisco School of MedicineClass of 1999
Stanford UniversityBS, Biology, Phi Beta Kappa, Honors, 1990 - 1994
Certifications & Licensure
CA State Medical License 2000 - 2026- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Join now to see all
Clinical Trials
- Valproic Acid in Treating Patients With Kaposi's Sarcoma Start of enrollment: 2005 Feb 01
- Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma Start of enrollment: 2005 Jun 01
- Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma Start of enrollment: 2006 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons.Pearse, W., Reid, E.> ;Surgical Oncology Clinics of North America. 2024 Apr 1
- 2 citationsASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma.Zurko, J. C., Rezvani, A. R., Narendranath Epperla, Ambuj Kumar, Syed A Abutalib, Farrukh T Awan, Yi-Bin Chen, Ajay K Gopal, Jennifer Holter-Chakrabarty, Natasha Kekre...> ;Transplantation and Cellular Therapy. 2023 Sep 1
- 2 citationsBrentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.Paul G Rubinstein, Page C Moore, Milan Bimali, Jeanette Y Lee, Michelle A Rudek, Amy Chadburn, Lee Ratner, David H Henry, Ethel Cesarman, Camille E DeMarco, Dominique ...> ;The Lancet. Haematology. 2023 Aug 1
- Join now to see all
Journal Articles
- Venetoclax, Bendamustine, and Rituximab in Patients with Relapsed or Refractory NHL: A Phase 1b Dose-Finding StudyN Fowler, E Reid, L J Nastoupil, Annals of Oncology
Abstracts/Posters
- Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...Erin G. Reid, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085Erin G. Reid, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Preliminary Safety and Anti-Tumor Activity of XmAb13676, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-HodgkinÍs Lymphoma and C...Erin G. Reid, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
How Much Work Are You Really Supposed to Do at Work?September 27th, 2021- Expert Q&A: Understanding the Oncogenic Role of HIV in Burkitt LymphomaAugust 27th, 2020
Three Things Lockdowns Have Exposed About Working and ParentingApril 27th, 2020- Join now to see all
Committees
- Co-Chair, NCCN Guideline Panel: Cancer in People Living with HIV 2016 - Present
- Co-Chair, NCCN Guideline Panel: AIDS-Related Kaposi Sarcoma 2016 - Present
- Member, NCCN Guideline Panel: B-Cell Lymphomas 2014 - Present
- Scientific Planning Committee, AIDS Malignancy Consortium 2013 - Present
- Steering Committee, AIDS Malignancy Consortium 2009 - Present
- Vice-Chair, Lymphoma Working Group, AIDS Malignancy Consortium, 2009 - Present
- Kaposi Sarcoma Working Group, AIDS Malignancy Consortium 2005 - Present
Professional Memberships
- Member
- Member
Hospital Affiliations
UC San Diego Medical Center - HillcrestSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
